Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.410
+0.030 (2.17%)
At close: Jun 6, 2025, 4:00 PM
1.430
+0.020 (1.41%)
After-hours: Jun 6, 2025, 7:30 PM EDT

Cardiol Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
116105543211272
Upgrade
Market Cap Growth
-32.75%93.06%67.34%-71.06%56.56%-21.55%
Upgrade
Enterprise Value
999424-169059
Upgrade
Last Close Price
1.411.280.840.511.852.18
Upgrade
PS Ratio
----1803.25-
Upgrade
PB Ratio
9.476.112.540.841.866.88
Upgrade
P/TBV Ratio
9.476.112.560.851.877.13
Upgrade
EV/Sales Ratio
----1441.08-
Upgrade
Debt / Equity Ratio
0.010.010.010.000.000.01
Upgrade
Asset Turnover
----0.00-
Upgrade
Quick Ratio
3.054.414.256.127.295.66
Upgrade
Current Ratio
3.264.524.366.277.545.94
Upgrade
Return on Equity (ROE)
-190.11%-138.47%-69.93%-48.16%-70.69%-147.74%
Upgrade
Return on Assets (ROA)
-89.03%-73.43%-37.71%-34.47%-46.58%-82.38%
Upgrade
Return on Capital (ROIC)
-132.69%-94.44%-46.14%-40.17%-53.83%-91.42%
Upgrade
Earnings Yield
-21.48%-24.30%-39.19%-70.37%-22.28%-22.60%
Upgrade
FCF Yield
-15.95%-16.61%-35.17%-62.10%-16.58%-10.04%
Upgrade
Buyback Yield / Dilution
-15.55%-11.02%-3.13%-44.61%-44.77%-15.63%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q